CAAIF Research Grant in Upper Airway Allergic Disease supported by AstraZeneca Canada

Eligibility

• The award must be held at a Canadian university or research institute defined as an eligible institution by CIHR
• Preference will be given to investigators who have not received CAAIF award within the past two years
• Application must align with CAAIF's mission statement
• Investigator-initiated studies of commercial pharmaceutical products eligible for industry sponsorship will not be considered except under special circumstances

Summary

ABOUT CAAIF
The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable foundation whose mission is to invest in research leading to new and better treatments that improve the lives of Canadians living with allergy, asthma and immunologic diseases.

ABOUT ASTRAZENECA CANADA
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines. The company employs roughly 1,200 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head, and neck cancer. The future of treatment for many of today's diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; Rare Disease; Respiratory & Immunology; and Vaccines & Immune Therapies. In 2021, AstraZeneca invested more than $135.6 million in Canadian health sciences research in our core therapy areas. For more information, please visit the company's website at www.astrazeneca.ca.

GRANT OBJECTIVE
The objective of the CAAIF Research Grant in Upper Airway Allergic Disease supported by AstraZeneca Canada is to fund a research grant focused on the area of upper airway allergic disease. 

VALUE OF THE AWARD
The maximum value of the award is $40,000.

DURATION
The Research Grant is for one year, non-renewable. 

Application deadlines

RSO final internal review deadline

Program application deadline

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

• Principal Investigator
• Department Head
• Faculty ADR/Dean
• Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.

Submission instructions:

1. Complete your application according to the agency guidelines
2. To initiate internal approvals, complete the Pre-Award/Application record in RMS (https://research.ucalgary.ca/conduct-research/additional-resources/resea...), attach your completed Application, and submit for approvals from your department head and/or faculty Associate Dean (Research). *Important: when submitting in RMS, please ensure that you allow time for academic approvals prior to the Research Services review deadline of 12:00pm on October 16, 2024
3. Once these approvals are obtained, RMS will automatically forward the Application record to Research Services for institutional review and approval.
4. Research Services will review, provide feedback (by email) if necessary, and will provide the institutional approval. If digital or wet-ink signatures are required, we will provide the capping institutional signature and will advise when ready.
5. Full Applications, including any supplementary documentation, should be submitted to the agency via the online submission form on October 21, 2024 by 9:59PM Mountain Time.